Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review

October 2021 | 59 pages | ID: M1E3F89E969EN
GlobalData

Abstracts

Misonix Inc (MSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Misonix Inc (Misonix) is a medical technology company that provides ultrasonic surgical devices for neurosurgical, spinal, advanced wound care and general surgery procedures. The company’s product portfolio includes BoneScalpel and BoneScalpel MIS cutting system; SonaStar surgical aspirator; SonicOne wound cleansing and debridement system, TheraSkin real human skin allograft, and Therion dehydrated and terminally sterilized allograft. Its products are used for orthopedic surgery, general surgery, neurosurgery, plastic surgery, maxillofacial surgery and wound care. It has a production facility in Farmingdale, New York, and sells products through direct salespersons and sales agents in the US and through an extensive network of distributors across the world. Misonix is headquartered in New York, the US.

Misonix Inc Key Recent Developments

Sep 02,2021: Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Aug 02,2021: Misonix’s proposed merger with Bioventus faces investigation
Jul 29,2021: Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
May 14,2021: Misonix Appoints Patrick J. Beyer to Board of Directors
May 06,2021: Misonix Reports Fiscal 2021 Third Quarter Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Misonix Inc - Key Facts
Misonix Inc - Key Employees
Misonix Inc - Key Employee Biographies
Misonix Inc - Major Products and Services
Misonix Inc - History
Misonix Inc - Company Statement
Misonix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Misonix Inc - Business Description
Business Segment: Surgical
Overview
Performance
Business Segment: Wound Care
Overview
Performance
Geographical Segment: Domestic
Performance
Geographical Segment: International
Performance
R&D Overview
Misonix Inc - Corporate Strategy
Misonix Inc - SWOT Analysis
SWOT Analysis - Overview
Misonix Inc - Strengths
Misonix Inc - Weaknesses
Misonix Inc - Opportunities
Misonix Inc - Threats
Misonix Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Misonix Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Misonix Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Misonix Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 02, 2021: Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results
Aug 02, 2021: Misonix’s proposed merger with Bioventus faces investigation
Jul 29, 2021: Misonix Reports Preliminary Fiscal 2021 Fourth Quarter and Full Year Revenue Results
May 14, 2021: Misonix Appoints Patrick J. Beyer to Board of Directors
May 06, 2021: Misonix Reports Fiscal 2021 Third Quarter Financial Results
Apr 20, 2021: Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May
Mar 01, 2021: Misonix to Participate in Upcoming March Investor Conferences
Feb 04, 2021: Misonix reports fiscal 2021 second quarter financial results
Jan 21, 2021: Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February
Oct 06, 2020: Misonix reports preliminary fiscal 2021 first quarter revenue of approximately $17.7 million

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Misonix Inc, Key Facts
Misonix Inc, Key Employees
Misonix Inc, Key Employee Biographies
Misonix Inc, Major Products and Services
Misonix Inc, History
Misonix Inc, Subsidiaries
Misonix Inc, Key Competitors
Misonix Inc, Ratios based on current share price
Misonix Inc, Annual Ratios
Misonix Inc, Annual Ratios (Cont...1)
Misonix Inc, Annual Ratios (Cont...2)
Misonix Inc, Interim Ratios
Misonix Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Misonix Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Misonix Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Misonix Inc, Performance Chart (2017 - 2021)
Misonix Inc, Ratio Charts
Misonix Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Misonix Inc, Medical Equipment, Deals by Type, 2015 to YTD 2021